130 related articles for article (PubMed ID: 1358910)
1. Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors.
Katznelson L; Oppenheim DS; Coughlin JF; Kliman B; Schoenfeld DA; Klibanski A
J Clin Endocrinol Metab; 1992 Nov; 75(5):1318-25. PubMed ID: 1358910
[TBL] [Abstract][Full Text] [Related]
2. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro.
de Bruin TW; Kwekkeboom DJ; Van't Verlaat JW; Reubi JC; Krenning EP; Lamberts SW; Croughs RJ
J Clin Endocrinol Metab; 1992 Nov; 75(5):1310-7. PubMed ID: 1430093
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.
Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT
J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
[TBL] [Abstract][Full Text] [Related]
6. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
7. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog).
Sy RA; Bernstein R; Chynn KY; Kourides IA
J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
9. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
Iglesias P; Díez JJ
J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
[TBL] [Abstract][Full Text] [Related]
10. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
Yoenem A; Cakyr B; Azal O; Corakcy A; Kutlu M; Oezata M
Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
[TBL] [Abstract][Full Text] [Related]
11. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
12. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
Deng J; Shi Y; Yin J
Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
[TBL] [Abstract][Full Text] [Related]
13. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
Caron P; Gerbeau C; Pradayrol L; Simonetta C; Bayard F
J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group.
Warnet A; Harris AG; Renard E; Martin D; James-Deidier A; Chaumet-Riffaud P
Neurosurgery; 1997 Oct; 41(4):786-95; discussion 796-7. PubMed ID: 9316039
[TBL] [Abstract][Full Text] [Related]
15. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.
Comi RJ; Gesundheit N; Murray L; Gorden P; Weintraub BD
N Engl J Med; 1987 Jul; 317(1):12-7. PubMed ID: 2884564
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.
Klibanski A; Deutsch PJ; Jameson JL; Ridgway EC; Crowley WF; Hsu DW; Habener JF; Black PM
J Clin Endocrinol Metab; 1987 Mar; 64(3):536-42. PubMed ID: 3102541
[TBL] [Abstract][Full Text] [Related]
17. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
18. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
19. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
Chayen SD; Gross D; Makhoul O; Glaser B
Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-secreting pituitary adenomas: report of seven cases.
Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]